BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+2.67%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$8.16B
AUM Growth
+$8.16B
(+3.8%)
Cap. Flow
+$212M
Cap. Flow
% of AUM
2.6%
Top 10 Holdings %
Top 10 Hldgs %
74.41%
Holding
115
New
7
Increased
22
Reduced
9
Closed
9
Top Buys
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
$76.6M |
| 2 |
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
|
$72M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$66.3M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$64.1M |
| 5 |
ARAV
Aravive, Inc. Common Stock
ARAV
|
$34.9M |
Top Sells
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$84.6M |
| 2 |
CHTP
CHELSEA THERAPEUTICS INT'L LTD
CHTP
|
$37.3M |
| 3 |
Halozyme
HALO
|
$28.9M |
| 4 |
Gilead Sciences
GILD
|
$24.9M |
| 5 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$20.1M |
Sector Composition
| 1 | Healthcare | 39.93% |